1-4 of 4
Friederike Berberich-Siebelt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Immune Checkpoint CD200/CD200R Decreases T Cell-Mediated Cytotoxicity Via Dok2 and Is Regulated By P53 in Multiple Myeloma

Pooja Shah, Thorsten Stuehmer, Larissa Haertle, Daniela Bruennert, Umair Munawar, Ellen Leich, Sabrina Kraus, Michael Hudecek, Manik Chatterjee, Andreas Schlosser, Martin Kortuem, Ralf C Bargou, Hermann Einsele, Friederike Berberich-Siebelt, Torsten Steinbrunn
Journal: Blood
Blood (2022) 140 (Supplement 1): 7076–7077.
https://doi.org/10.1182/blood-2022-166283
Published: 2022
Journal Articles

CD200 Expression on Multiple Myeloma Cells Induces Attenuation of T Cell-Mediated Cytotoxicity Via DOK2

Pooja Shah, Thorsten Stuehmer, Daniela Bruennert, Umair Munawar, Ellen Leich, Sabrina Kraus, Michael Hudecek, Manik Chatterjee, Andreas Schlosser, Ralf C Bargou, Hermann Einsele, Friederike Berberich-Siebelt, Torsten Steinbrunn
Journal: Blood
Blood (2021) 138 (Supplement 1): 1587.
https://doi.org/10.1182/blood-2021-153741
Published: 2021
Journal Articles

Averted NFATc1 Sumoylation in Alloreactive T Cells Ameliorates Acute GvHD

Musga Qureischi, MSc, Lena Dietz, PhD, Martin Vaeth, PhD, Andreas Beilhack, MD, Friederike Berberich-Siebelt, PD PhD
Journal: Blood
Blood (2016) 128 (22): 809.
https://doi.org/10.1182/blood.V128.22.809.809
Published: 2016
Journal Articles

A Selective TNFR2 Agonist Expands Host T reg Cells in Vivo to Protect from Acute Graft-Versus-Host Disease

Andreas Beilhack, MD, Martin Chopra, PhD, Marlene Biehl, Martin Vaeth, PhD, Andreas Brandl, PhD, Jorge Amich, PhD, Janina Findeis, Ana-Laura Jordán Garrote, PhD, Christian Brede, PhD, Carina A Bäuerlein, PhD, Stefanie Schwinn, Hermann Einsele, MD, Friederike Berberich-Siebelt, PhD, Harald Wajant, PhD
Journal: Blood
Blood (2014) 124 (21): 1099.
https://doi.org/10.1182/blood.V124.21.1099.1099
Published: 2014